Edgewise Therapeutics Inc (EWTX)

Edgewise Therapeutics Inc (EWTX) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
기간	3개월	3개월	3개월	3개월	3개월
	25.51%46.14	61.94	54.12	55.98	46.86
Research and Development	33.59%31.58	47.55	42.65	43.59	37.48
Operating Income/Loss	25.51%-46.14	-61.94	-54.12	-55.98	-46.86
Nonoperating Income/Loss	1,367.63	-	-	-	-
Income/Loss From Continuing Operations Before Tax	1,321.48	-	-	-50.22	-40.67
Income Tax Expense/Benefit	155.33	-	-	-	-
	2,134%1,166.15	-57.33	-49.01	-50.22	-40.67
Attributable To Parent	2,134%1,166.15	-57.33	-49.01	-50.22	-40.67
Available To Common Stockholders, Basic	1,166.15	-	-	-50.22	-40.67
Basic Average Shares	1.12%108.87	107.67	107.12	1.04	105.49
Diluted Average Shares	12.26%120.87	107.67	107.12	1.04	105.49
Basic Earnings Per Share	2,121%10.71	-0.53	-0.46	-0.48	-0.39
Diluted Earnings Per Share	1,921%9.65	-0.53	-0.46	-0.48	-0.39